Karyopharm Therapeutics Inc. (KPTI)
NASDAQ: KPTI · Real-Time Price · USD
9.51
+0.13 (1.39%)
At close: Jul 17, 2026, 4:00 PM EDT
8.69
-0.82 (-8.64%)
After-hours: Jul 17, 2026, 7:49 PM EDT
Karyopharm Therapeutics Market Cap
Karyopharm Therapeutics has a market cap or net worth of $215.52 million as of July 17, 2026. Its market cap has increased by 497.02% in one year.
Market Cap
215.52M
Enterprise Value
427.89M
1-Year Change
497.02%
Ranking
Category
Stock Price
$9.51
ChartMarket Cap Chart
Since November 6, 2013, Karyopharm Therapeutics's market cap has decreased from $442.90M to $215.52M, a decrease of -51.34%. That is a compound annual growth rate of -5.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 215.50M | 71.71% |
| Dec 31, 2025 | 125.50M | 48.17% |
| Dec 31, 2024 | 84.70M | -14.53% |
| Dec 29, 2023 | 99.10M | -64.08% |
| Dec 30, 2022 | 275.90M | -43.21% |
| Dec 31, 2021 | 485.80M | -57.36% |
| Dec 31, 2020 | 1.14B | -5.35% |
| Dec 31, 2019 | 1.20B | 111.62% |
| Dec 31, 2018 | 568.80M | 25.59% |
| Dec 29, 2017 | 452.90M | 16.82% |
| Dec 30, 2016 | 387.70M | -18.12% |
| Dec 31, 2015 | 473.50M | -61.32% |
| Dec 31, 2014 | 1.22B | 79.50% |
| Dec 31, 2013 | 681.90M | 53.96% |
| Nov 6, 2013 | 442.90M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Compugen | 223.22M |
| Nautilus Biotechnology | 223.02M |
| Anavex Life Sciences | 221.95M |
| Invivyd | 220.87M |
| Orchestra BioMed Holdings | 218.56M |
| Coherus Oncology | 214.41M |
| AC Immune | 211.79M |
| Keros Therapeutics | 211.57M |